Prevalence of hypouricaemia and SLC22A12 mutations in healthy Korean subjects

Nephrology

Volumn 13, Issue 8, 2008, Pages 661-666

  Lee, Joo Hoon ^a,e   Choi, Hyun Jin ^a   Lee, Beom Hee ^a   Kang, Hee Kyung ^a   Chin, Ho Jun ^b,c   Yoon, Hyung Jin ^d   Ha, Il Soo ^a,c   Kim, Suhnggwon ^c,d   Choi, Yong ^a,c   Cheong, Hae Il ^a,c  

^a Seoul National University Children's Hospital   (South Korea)

^b Seoul National University Bundang Hospital   (South Korea)

^c Seoul National University College of Medicine   (South Korea)

^d Seoul National University Hospital   (South Korea)

^e University of Ulsan College of Medicine   (South Korea)

Author keywords

Common mutation; Hyperuricaemia; Hypouricaemia; SLC22A12 gene; URAT1

Indexed keywords

CARRIER PROTEINS AND BINDING PROTEINS; PROTEIN SLC22A12; UNCLASSIFIED DRUG; URIC ACID;

ADULT; ARTICLE; BLOOD PRESSURE; CONTROLLED STUDY; FEMALE; GENE FREQUENCY; GENE MUTATION; GENOTYPE; HUMAN; HYPERURICEMIA; HYPOURICEMIA; KIDNEY HYPOURICEMIA; KOREA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; SEX DIFFERENCE; URIC ACID BLOOD LEVEL;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; BLOOD PRESSURE; CREATININE; FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLUCOSE TRANSPORT PROTEINS, FACILITATIVE; HUMANS; HYPERURICEMIA; KIDNEY DISEASES; KOREA; MALE; MIDDLE AGED; MUTATION; PHENOTYPE; PREVALENCE; SEX FACTORS; URIC ACID;

EID: 58149127353     PISSN: 13205358     EISSN: 14401797     Source Type: Journal    
DOI: 10.1111/j.1440-1797.2008.01029.x     Document Type: Article

References (34)

1. Enomoto A, Kimura H, Chairoungdua A et al. Molecular identification of a renal urate anion exchanger that regulates blood urate levels. Nature 2002 417 : 447 52.
2. Iwai N, Mino Y, Hosoyamada M, Tago N, Kokubo Y, Endou H. A high prevalence of renal hypouricemia caused by inactive SLC22A12 in Japanese. Kidney Int. 2004 66 : 935 44.
3. Maesaka JK, Fishbane S. Regulation of renal urate excretion: A critical review. Am. J. Kidney Dis. 1998 32 : 917 33.
4. Ramsdell CM, Kelley WN. The clinical significance of hypouricemia. Ann. Internal Med. 1973 78 : 239 42.
5. Yanase M, Nakahama H, Mikami H, Fukuhara Y, Orita Y, Yoshikawa H. Prevalence of hypouricemia in apparently normal population. Nephron 1988 48 : 80
6. Takahashi T, Tsuchida S, Oyamada T et al. Recurrent URAT1 gene mutations and prevalence of renal hypouricemia in Japanese. Pediatr. Nephrol. 2005 20 : 576 8.
7. Bairaktari ET, Kakafika AI, Pritsivelis N et al. Hypouricemia in individuals admitted to an inpatient hospital-based facility. Am. J. Kidney Dis. 2003 41 : 1225 32.
8. Ogino K, Hisatome I, Saitoh M et al. Clinical significance of hypouricemia in hospitalized patients. J. Med. 1991 22 : 76 82.
9. Ohta T, Sakano T, Ogawa T et al. Exercise-induced acute renal failure with renal hypouricemia: A case report and a review of the literature. Clin. Nephrol. 2002 58 : 313 6.
10. Hirasaki S, Koide N, Fujita K, Ogawa H, Tsuji T. Two cases of renal hypouricemia with nephrolithiasis. Intern. Med. 1997 36 : 201 5.
11. Hisatome I, Tanaka Y, Ogino K et al. Hematuria in patients with renal hypouricemia. Intern. Med. 1998 37 : 40 6.
12. Komoda F, Sekine T, Inatomi J et al. The W258X mutation in SLC22A12 is the predominant cause of Japanese renal hypouricemia. Pediatr. Nephrol. 2004 19 : 728 33.
13. Ichida K, Hosoyamada M, Hisatome I et al. Clinical and molecular analysis of patients with renal hypouricemia in Japan-influence of URAT1 gene on urinary urate excretion. J. Am. Soc. Nephrol. 2004 15 : 164 73.
14. Cheong HI, Kang JH, Lee JH et al. Mutational analysis of idiopathic renal hypouricemia in Korea. Pediatr. Nephrol. 2005 20 : 886 90.
15. Tzovaras V, Chatzikyriakidou A, Bairaktari E, Liberopoulos EN, Georgiou I, Elisaf M. Absence of SLC22A12 gene mutations in Greek Caucasian patients with primary renal hypouricaemia. Scand. J. Clin. Lab. Invest. 2007 67 : 589 95.
16. Graessler J, Graessler A, Unger S et al. Association of the human urate transporter 1 with reduced renal uric acid excretion and hyperuricemia in a German Caucasian population. Arthritis Rheum. 2006 54 : 292 300.
17. Vázquez-Mellado J, Jiménez-Vaca AL, Cuevas-Covarrubias S, Alvarado-Romano V, Pozo-Molina G, Burgos-Vargas R. Molecular analysis of the SLC22A12 (URAT1) gene in patients with primary gout. Rheumatology 2007 46 : 215 9.
18. Johnson RJ, Rideout BA. Uric acid and diet - insights into the epidemic of cardiovascular disease. N. Engl. J. Med. 2004 350 : 1071 3.
19. Hosoyamada M, Ichida K, Enomoto A, Hosoya T, Endou H. Function and localization of urate transporter 1 in mouse kidney. J. Am. Soc. Nephrol. 2004 15 : 261 8.
20. Li T, Walsh JR, Ghishan FK, Bai L. Molecular cloning and characterization of a human urate transporter (hURAT1) gene promoter. Biochim. Biophys. Acta 2004 1681 : 53 8.
21. Johnson RJ, Kang DH, Feig D et al. Is there a pathogenetic role for uric acid in hypertension and cardiovascular and renal disease?. Hypertension 2003 41 : 1183 90.
22. Nagahama K, Inoue T, Iseki K et al. Hyperuricemia as a predictor of hypertension in a screened cohort in Okinawa, Japan. Hypertens. Res. 2004 27 : 835 41.
23. Alper AB Jr., Chen W, Yau L, Srinivasan SR, Berenson GS, Hamm LL Childhood uric acid predicts adult blood pressure: The Bogalusa Heart Study. Hypertension 2005 45 : 34 8.
24. Sundstrom J, Sullivan L, D'Agostino RB, Levy D, Kannel WB, Vasan RS. Relations of serum uric acid to longitudinal blood pressure tracking and hypertension incidence. Hypertension 2005 45 : 28 33.
25. Feig DI, Nakagawa T, Karumanchi SA et al. Hypothesis: Uric acid, nephron number, and the pathogenesis of essential hypertension. Kidney Int. 2004 66 : 281 7.
26. Mazzali M, Hughes J, Kim YG et al. Elevated uric acid increases blood pressure in the rat by a novel crystal-independent mechanism. Hypertension 2001 38 : 1101 6.
27. Mazzali M, Kanellis J, Han L et al. Hyperuricemia induces a primary renal arteriolopathy in rats by a blood pressure-independent mechanism. Am. J. Physiol. Renal Physiol. 2002 282 : F991 7.
28. Khosla UM, Zharikov S, Finch JL et al. Hyperuricemia induces endothelial dysfunction. Kidney Int. 2005 67 : 1739 42.
29. Kang DH, Nakagawa T, Feng L et al. A role for uric acid in the progression of renal disease. J. Am. Soc. Nephrol. 2002 13 : 2888 97.
30. Golembiewska E, Ciechanowski K, Safranow K, Kedzierska K, Kabat-Koperska J. Renal handling of uric acid in patients with type 1 diabetes in relation to glycemic control. Arch. Med. Res. 2005 36 : 32 5.
31. Bonones RW, Dana ES. On the increased uric acid clearance following the intravenous infusion of hypertonic glucose solutions. J. Clin. Invest. 1946 25 : 386 8.
32. Gonzalez-Sicilia L, Garcia-Estan J, Martinez-Blazquez A, Fernandez-Pardo J, Quiles JL, Hernandez J. Renal metabolism of uric acid in type I insulin-dependent diabetic patients: Relation to metabolic compensation. Horm. Metab. Res. 1997 29 : 520 3.
33. Hisatome I, Kotake H, Ogino K et al. Hypouricaemia with acute viral hepatitis. Br. J. Rheumatol. 1989 28 : 525 7.
34. Decaux G, Mols P, Naeije R, Reding P. Hypouricemia in cirrhosis reflects hemodynamic alterations. Metabolism 1984 33 : 750 3.